Erenumab-Aooe
Brand names: Aimovig Autoinjector
At a glance
- Medicare prescriptions, 2024
- 266,341
- Medicare drug cost
- $231.7M
- Average cost per prescription
- $870
- Clinicians who prescribed it
- 8,132
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
AIMOVIG is indicated for the preventive treatment of migraine in adults. AIMOVIG is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults.
From the FDA-approved prescribing information (label dated July 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Neurology 56.6%
- Nurse Practitioners 21.5%
- Physician Assistants 10.0%
- Family Medicine 4.6%
- Internal Medicine 2.6%
- Pain Medicine 1.4%
- Physical Medicine & Rehabilitation (PM&R) 0.7%
- Sleep Medicine 0.4%
- Child Neurology 0.3%
- Osteopathic Manipulative Medicine 0.2%
- General Practice 0.2%
- Ophthalmology 0.1%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 80% from 2019 to 2024.
Biggest change by state since 2019
- Georgia +131%
- Illinois +117%
- Texas +99%
- Indiana +94%
- Florida +84%
- Arizona (smallest change) +37%
- California (smallest change) +47%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
Industry payments about this drug
Drug makers reported $866 in payments to clinicians that named this drug in 2025 (meals, speaking, consulting and similar).
- Amgen Inc. $866
Source: CMS Open Payments, general payments (not research), program year 2025. A payment is not evidence of wrongdoing. Payments by doctor
Recalls and shortages
Not on the FDA drug shortage list.
No FDA-reported recalls since 2020.
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.